Key Players in the Antinuclear Antibody Test Market by Product Have a Major Focus on Acquisitions, New Product Launches, Agreements, and Expansions
The Global Antinuclear Antibody Test Market by Product is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%.
The Antinuclear Antibody Test Market by Product is segmented into five major disease segments, namely, rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma, and other diseases. Other diseases include Raynaud’s Syndrome, polymyositis, mixed connective...